News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

A Bankrupt KV Pharmaceutical Now Goes After Some States


8/7/2012 7:24:23 AM

At the same time that KV Pharmaceutical was preparing long-threatened bankruptcy papers, the besieged drugmaker also filed a pair of lawsuits against two state Medicaid programs for failing to cover their controversial Makena treatment for premature births. The lawsuits, which were filed against Georgia and South Carolina, followed a lawsuit filed last month against the FDA for failing to prevent some compounding pharmacies from offering lower-cost versions of Makena. KV Pharma “has been unable to realize the full value of its most important product, Makena because of a lack of enforcement of the orphan drug marketing exclusivity granted to K-V for Makena by the FDA,” KV ceo Greg Divis says in a statement. “The lack of enforcement has also led certain state Medicaid agencies to impose barriers to access to Makena on low-income pregnant women at high risk for recurrent preterm birth, despite those states’ legal obligation to cover FDA-approved drugs.”

Read at Pharmalot

comments powered by Disqus
Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES